Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sino Biopharmaceutical Limited
  6. News
  7. Summary
    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sino Biopharmaceutical : Antibacterial Drug Wins Regulatory OK in China

06/03/2021 | 12:53am EDT


ę MT Newswires 2021
All news about SINO BIOPHARMACEUTICAL LIMITED
08/02SINO BIOPHARMACEUTICAL : Biopharm's Hypertension Drug Wins Marketing Approval in..
MT
07/30SINO BIOPHARMACEUTICAL : Biopharm's Neuroprotective Agent Wins Registration Appr..
MT
07/29Sino Biopharmaceutical Limited Announces "Edaravone Injection" Obtains Drug R..
CI
07/28SINO BIOPHARMACEUTICAL : Biopharm's Antidepressant Wins Registration Approval in..
MT
07/27Sino Biopharmaceutical Limited commences an Equity Buyback Plan for 1,886,149..
CI
07/27SINO BIOPHARMACEUTICAL : China Approves Sino Biopharm's Liver Cancer Drug
MT
07/26SINO BIOPHARMACEUTICAL : Voluntary announcement - "lenvatinib mesilate capsule" ..
PU
07/26Sino Biopharmaceutical Limited Announces Lenvatinib Mesilate Capsule Has Obta..
CI
07/22SINO BIOPHARMACEUTICAL : Donates Cash and Supplies Valued at RMB10 Million to Su..
AQ
07/16SINO BIOPHARMACEUTICAL : Biopharm's Antiemetic Wins Registration Approval, Passe..
MT
More news
Financials
Sales 2021 34 259 M 4 406 M 4 406 M
Net income 2021 6 232 M 801 M 801 M
Net cash 2021 9 842 M 1 266 M 1 266 M
P/E ratio 2021 20,4x
Yield 2021 1,24%
Capitalization 126 B 16 155 M 16 147 M
EV / Sales 2021 3,38x
EV / Sales 2022 2,67x
Nbr of Employees 24 262
Free-Float 52,4%
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO BIOPHARMACEUTICAL LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 6,69 HKD
Average target price 11,19 HKD
Spread / Average Target 67,3%
EPS Revisions
Managers and Directors
Yi Li Chief Executive Officer & Executive Director
Theresa Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Mao Li Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
SINO BIOPHARMACEUTICAL LIMITED-10.80%16 155
JOHNSON & JOHNSON9.46%453 498
ROCHE HOLDING AG13.88%339 298
PFIZER, INC.19.42%246 075
NOVARTIS AG0.14%225 528
ELI LILLY AND COMPANY46.06%224 166